探索代谢功能障碍相关的脂肪肝疾病和青少年亚临床甲状腺功能低下症之间的联系:综合性综述
Xinlong Hu1, Wenzai Shi2, Guoshuai Xu1
1Department of General Surgery, Aerospace Center Hospital, Beijing, China.
Frontiers in pediatrics
|March 4, 2026
概括
代谢功能障碍相关的脂肪肝疾病 (MAFLD) 和亚临床甲状腺功能低下症 (SCH) 在青少年中通过代谢和内分泌途径联系在一起. 需要进一步的研究来确认因果关系,并指导针对这些常见疾病的干预措施.
科学领域:
- 儿科内分泌学 儿科内分泌学
- 肝病学 肝病学是一种肝病学.
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 代谢功能障碍相关的脂肪肝疾病 (MAFLD) 和亚临床甲状腺功能低下症 (SCH) 在青少年中经常同时发生.
- 这种伴随性疾病在年轻人中的确切关系和临床意义尚不清楚.
研究的目的:
- 综合现有的关于MAFLD和SCH在青少年之间的流行病学关联的证据.
- 探索共同的潜在机制,并讨论对管理这些疾病的临床影响.
主要方法:
- 进行了对主要科学数据库 (PubMed,Embase,Web of Science,Cochrane Library) 的结构化审查.
- 包括儿科观察研究和相关的机械或干预数据.
- 数据提取的重点是研究设计,诊断标准,甲状腺功能测试,肝脏结果和调整后的效果估计.
主要成果:
- 在儿科队列中发现TSH水平升高和肝硬化症严重程度增加之间存在一致的关联.
- 可能的机械联系包括TSHR-SREBP-1c信号传递,胰岛素耐药性和肠-肝-甲状腺轴相互作用.
- 成人研究表明,甲对于肝脏参数具有潜在的益处,但儿科数据有限.
结论:
- 在青少年中,MAFLD和SCH通过代谢和内分泌途径相互联系,尽管因果关系需要进一步调查.
- 基于风险的查策略 (甲状腺检测在MAFLD中,肝脏评估在SCH中) 可能是有益的.
- 长度研究和儿科试验对于确定干预值和评估内分泌管理的有效性至关重要.
相关概念视频
Functions of Thyroid Hormones
5.8K
The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
5.8K
Overview of Lipid Metabolism
7.0K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
7.0K
Hyperthyroidism I: Introduction
30
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
30
Hyperthyroidism II: Pathophysiology
28
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH...
28
Hypothyroidism II: Pathophysiology
26
Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
26
Type II Diabetes I: Introduction
17
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
17


